LGALS9 and cancer: To further characterize these clusters, cancer cell/ neutrophil co-cultures were treated with Gal-9 and cell aggregates were evaluated by flow cytometry using EpCAM and CD16 as cancer and neutrophil markers, respectively (Figure 4C).